Laser therapy for disc herniations

What is Percutaneous Laser Disc Decompression - PLDD treatment

It is a minimally invasive, percutaneous procedure that can treat lumbar, thoracic and cervical (except for the T1-T5 segment) disc hernias by introducing a thin 18/20 G needle into the area of interest, which must gradually reach the centre of the nucleus pulposus.

A slender, thin fiber, less than half a millimeter in size, comes into contact with the nucleus pulposus through the needle. Laser light is consequently emitted which leads to the vaporisation (water absorption) of part of the nucleus pulposus, thereby reducing pressure inside the discs and on the spinal nerve, achieving an immediate improvement in symptoms.

 

Is the procedure painful? 

No, the procedure is not painful as it is performed under local anaesthesia.

 

How long does the procedure last? 

The procedure lasts for around 15-20 minutes.

 

Will there be any scars? 

No scars as the procedure is performed via a spinal injection using a very thin needle.

 

How long must you rest after the procedure?

Resumption of activities of daily living is immediate, as only two hours of rest are needed for both lumbar and cervical procedures.

 

How do you feel immediately after the procedure? 

There is immediate pain relief.

 

Is it possible to simultaneously treat multiple hernias?

Yes, it is possible to simultaneously treat multiple hernias.

 

What are the cases where PLDD is not indicated? 

The results have proved negative for extruded discs, migrated discs and in cases of degenerated black discs.

 

What are the contraindications? 

None.

EUFOTON TREATMENT FINDER

Find a doctor in your area!

keyboard_arrow_rightAre you a health worker?keyboard_arrow_down

!

!

Disclosures
Some of the information contained in this website are exclusively directed to healthcare professionals, in compliance with art. 21 of the Decree n. 46 of February 24th, 1997 and subsequent modifications and integrations, and the Guidelines of the Italian Ministry of Health of March 28th, 2013. The possibility to continue browsing and access to the content relating to products, technical descriptions and commercial offers is subject to the statement made by the user, under his own responsibility, to be a healthcare professional. The simple visitors will be redirected to institutional page of Eufoton.
Cookie Policy

This website uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Find out more by clicking here. ABILITA or DISABILITA.

By pressing Continue I declare under my own responsibility to be a healthcare provider and continuing to browse I declare to accept the cookie information.

I am a health worker
Continue arrow_forward
I am a visitor
Home arrow_forward